Eyecelerator, a partner of the American Academy of Ophthalmology, is self-described as having the goal of advancing eye care ...
Preoperative identification and eradication of Demodex can improve ocular-surface comfort and may mitigate cataract-surgery ...
Oculis Holding AG announced that the final patient visit has been completed in the DIAMOND phase 3 program assessing OCS-01, ...
Propensity-matched analyses showed smokers had significantly higher risk across all studied ocular outcomes over 10 years, ...
Christopher E. Starr, MD, FACS, highlights diagnostic gaps in dry eye, emphasizing neuropathic corneal pain and reviewing ...
Self-reported hearing impairment reduced the likelihood of achieving clinically meaningful functional improvement after ...
New 52-week analyses from the phase 3 SOL-1 trial suggest that the investigational intravitreal therapy AXPAXLI (OTX-TKI) may ...
Dr. Khanani reviews 52-week safety outcomes, noting Axpaxli was generally well tolerated with no cases of endophthalmitis or retinal vasculitis. Dr. Khanani reviews 52-week safety outcomes, noting ...
A tissue-sparing technique using a triple-layer decellularized basement membrane is associated with shorter OR time, rapid recovery, and no reported recurrences in a retrospective series. A ...
CME courses and educational resources on Ophthalmology Times - Clinical Insights for Eye Specialists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results